A Cleveland Clinic analysis of nearly 8,000 patients found that discontinuing semaglutide and tirzepatide did not lead to significant immediate weight regain in clinical practice
The FDA classifies Thrive GLP-1 as a dietary supplement, not a drug
Probabilistic inference and strategic ranking should only be undertaken once outcome definitions, time windows, and network geometry have reached a state of stability
The intervention group consisted of patients who were prescribed GLP-1 RA medications, including Victoza (Liraglutide 1.8 mg), Saxenda (Liraglutide 3 mg), Ozempic (Semaglutide 1 mg), and Wegovy (Semaglutide 2.4 mg)
In certain amounts, prebiotic fiber can activate the release of GLP-1 (Glucagon-Like Peptide-1), a hormone that helps regulate appetite, slow stomach emptying, and promote feelings of fullness
There are no published studies on the matter